Vor Biopharma Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
Business Address 500 BOYLSTON STREET, BOSTON, MA, 02116
Mailing Address 500 BOYLSTON STREET, BOSTON, MA, 02116
Phone 617-655-6580
Fiscal Year End 1231
EIN 811591163
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 16, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | January 29, 2026 | View on SEC |
Annual Reports
10-K March 30, 2026
- Strategic pivot to telitacicept for autoimmune conditions like Lupus and IgA Nephropathy.
- Successful $100 million capital raise in early 2025 to fund clinical development.
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB Biological Products, (No Diagnostic Substances)
BRAINSTORM CELL THERAPEUTICS INC.
BCLI Biological Products, (No Diagnostic Substances)
Alvotech
ALVO Biological Products, (No Diagnostic Substances)
Liminatus Pharma, Inc.
LIMN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.